Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DBS and LVA in Severe Alzheimer's Disease
NCT07094438Phase 1Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial (3 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: Alzheimer's Disease Assessment Scale - Cognitive Subscale at 18 months, Mini-Mental State Examination at 18 months and 1 more. Started Jan 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07094438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07094438.